From Financial Modeling Prep: 2025-03-10 11:06:00

JPMorgan analysts upgraded DocuSign (NASDAQ:DOCU) from Underweight to Neutral, with a new price target of $75, up from $70. The decision reflects signs of fundamental improvement in the stock. DocuSign has been range-bound between $50 and $110 over the past three years, declining about 25% since its fiscal Q3 earnings report in December.

Despite a prolonged correction, JPMorgan views DocuSign’s valuation as relatively undemanding, with early signs of stabilization in its business fundamentals. The company is in a post-pandemic reset phase, working through accelerated demand pull-forward impacts. There is potential for growth rate stabilization or improvement in the near term, leading to a more balanced risk-reward profile.



Read more at Financial Modeling Prep:: JPMorgan Upgrades DocuSign to Neutral Amid Signs o…